These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6157754)
21. [The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma]. Shcherbakov AB; Remenson EI; Kirsanova ID; Basnak'ian AG; Guseva NG Ter Arkh; 1992; 64(5):73-5. PubMed ID: 1333647 [TBL] [Abstract][Full Text] [Related]
22. [Significance of anti-centromere antibodies. Clinical value]. Meyer O; Haim T; Ryckewaert A Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931 [TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibody in localised scleroderma. Sato S; Fujimoto M; Hasegawa M; Takehara K Ann Rheum Dis; 2003 Aug; 62(8):771-4. PubMed ID: 12860735 [TBL] [Abstract][Full Text] [Related]
24. Profiles of antibodies to poly(ADP-ribose), left-handed Z-DNA, and other nuclear constituents in systemic lupus erythematosus and progressive systemic sclerosis. Kanai Y; Moroi Y; Yokohari R; Goto S Princess Takamatsu Symp; 1983; 13():93-100. PubMed ID: 6654833 [TBL] [Abstract][Full Text] [Related]
25. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403 [TBL] [Abstract][Full Text] [Related]
26. [Anti-nucleic acid antibodies in children with systemic lupus erythematosus and systemic scleroderma and in their relatives living with the probands]. Adamashvili IM; Makarova OV; Zamchuk LA; Gvardzhaladze TV Revmatologiia (Mosk); 1991; (4):13-6. PubMed ID: 1725222 [TBL] [Abstract][Full Text] [Related]
27. Occurrence of antibodies to single-stranded DNA in ANA negative patients. Wasicek CA; Maddison PJ; Reichlin M Clin Exp Immunol; 1979 Aug; 37(2):190-5. PubMed ID: 315286 [TBL] [Abstract][Full Text] [Related]
28. Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states. Locker JD; Medof ME; Bennett RM; Sukhupunyaraksa S J Immunol; 1977 Feb; 118(2):694-701. PubMed ID: 300090 [TBL] [Abstract][Full Text] [Related]
29. Antibodies to single-stranded DNA in patients with discoid lupus erythematosus. Kulick KB; Provost TT; Reichlin M Arthritis Rheum; 1982 Jun; 25(6):639-46. PubMed ID: 6178416 [TBL] [Abstract][Full Text] [Related]
30. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma. Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181 [TBL] [Abstract][Full Text] [Related]
31. Immunologic regulation of spontaneous antibodies to DNA and RNA I. Significance of IgM and IgG antibodies in SLE patients and asymptomatic relatives. Talal N; Pillarisetty RJ; DeHoratius RJ; Messner RP Clin Exp Immunol; 1976 Sep; 25(3):377-82. PubMed ID: 1085677 [TBL] [Abstract][Full Text] [Related]
32. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma]. Butov IuS; Skripkin IuK; Koshevenko IuN Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599 [No Abstract] [Full Text] [Related]
33. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976 [TBL] [Abstract][Full Text] [Related]
34. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis. Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764 [TBL] [Abstract][Full Text] [Related]
35. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease. Parker MD J Lab Clin Med; 1973 Nov; 82(5):769-75. PubMed ID: 4583583 [No Abstract] [Full Text] [Related]
36. [Connective tissue diseases and HEp-2 antinuclear antibodies]. Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632 [TBL] [Abstract][Full Text] [Related]
37. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Rosenbaum J; Pottinger BE; Woo P; Black CM; Loizou S; Byron MA; Pearson JD Clin Exp Immunol; 1988 Jun; 72(3):450-6. PubMed ID: 3168322 [TBL] [Abstract][Full Text] [Related]
38. Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Wallace DJ; Lin HC; Shen GQ; Peter JB Arthritis Rheum; 1994 Dec; 37(12):1795-7. PubMed ID: 7986226 [TBL] [Abstract][Full Text] [Related]
39. A quantitative radioimmunoassay for DNA-binding antibodies. Smith LH; Guyer RL; Minami RM; Teplitz RL J Lab Clin Med; 1981 Sep; 98(3):425-36. PubMed ID: 7264438 [TBL] [Abstract][Full Text] [Related]
40. [A case report of typical scleroderma accompanied with serum abnormalities characteristic of SLE during the course]. Nishiyama S; Kakihara H; Miyawaki S Ryumachi; 1997 Feb; 37(1):24-9. PubMed ID: 9128420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]